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CANCER STEM CELLS
Cancer was always the most common cause of mortality in the past and is still today. In the past few decades, stem cell biology has provided new approaches and research into cancer biology. 25 It is now believed that tumor cells have the stem cell properties of selfrenewal and differentiation to generate mature cells. These cells are called cancer stem cells (CSCs), which have the ability to produce distinct cell types that are found in their original tumor (Flow Chart 1). 5, 6 It is still unclear whether the CSCs are derived by transformation of stem cells or are due to differentiation of mature neoplastic cells. 58 The
CSCs were actually first discovered in the hematopoi etic system. 5, 9, 10 Cancer stem cellrich tumors have high metastatic rate and poor prognosis as they have increased resistance to chemotherapeutic agents. 5, 1113 It is generally accepted that cancer may arise from tissue stem cells through genetic and epigenetic changes and CSCs are recognized by the presence or absence of different cell surface markers.
INTRODUCTION
Cancer, despite its recent treatment therapies, has been the most common cause of morbidity and mortality world wide. Stem cells are being used for decades as one of the methods for cancer therapy. 1 Stem cells are undifferenti ated cells, which give rise to other cells. They have two unique characteristics: The ability to selfrenewal, which means that they can multiply and produce numerous cells of themselves, and the ability to differentiate, which means, it can change into two or more different types of Flow Chart 1: Cancer stem cell arising from stem cell, progenitor, and differentiated cell and central nervous system cancers, such as glioblastoma and medulloblastoma. 15 The selfrenewal ability of stem cell is regulated by signals from the surrounding stem cells called niche, and the alteration in this niche signaling has been observed in human Tcell acute lymphoblastic leukemia and cervical and breast cancer. According to past literature and studies, it is proposed that breast cancers may arise from mammary stem cells that have undergone transformations or from the early progenitor cells. 16 Head and neck cancer is the sixth most common cancer in the global population. Research on head and neck CSCs has started recently in the year 2007. Mortality rate in head and neck cancer is usually due to metastasis to lymph nodes and distant organs, and CSCs act as important purveyors of metastasis.
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Cancer Stem Cells and Therapeutic Approach
Eradication of cancer is concerned with targeting and elimination of these CSCs sparing the normal stem cells. But, there are always challenges to implementing such strategies as both share similar properties of selfrenewal; however, with recent studies using animal models, these strategies can be approachable. 16 Cancer stem cells are identified, which has brought important therapeutic implications. According to Gil et al, 21 the resistance of these CSCs to chemotherapy may be caused by increased expression of proteins from the Bcell lymphoma 2 family, which actually leads to an increase in expression of mem brane proteins, which are responsible for drug resistance. 21 In tumors, CSCs play a role in three ways: Mutation of normal cells into cancer cells, ultimately leading to the primary tumor; they may also play a role in the recur rence of the tumor and can migrate causing metastasis. 1, 22 Gene expression profile of CSCs is different and by com paring it with the bulk tumor population, normal stem cells, and tissues, there may be a possibility in identifying therapeutic targets that preferentially attack CSCs. 2, 15, 23 Cancer stem cell biomarkers are used as a tool to identify CSCs as well as become target of many drugs developed for its cure. In recent years, many markers have been identified, which include CD133, CD44, ABCG2, and some other cell surface proteins. CD133 is a glycosylated protein used for the identification of brain tumor, lung, pancreatic, liver, prostate, colorectal, and head and neck cancers. CD44 has been used to identify cancers of the breast, pancreas, head and neck, ovarian, and colon. ABCG2 plays a role in the maintenance of stem cell phenotype and helps in identifying cancers of lung, liver, brain, prostrate, etc. 24 There are many other noncarbohydrate stem cell markers, which are also CSC markers, such as Bmi1, CD29, CD44, CD90, CD117, Nestin. 25 Natural compounds, such as salinomycin, curcumin, sulforaphane have also been found in recent years to have the ability to kill CSCs.
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Cancer Stem Cells and Its Response to Chemotherapy
The response to chemotherapy becomes an issue when there is a recurrence of the tumor. The recurrent tumor may arise due to the survival of CSCs present within the primary tumor despite chemotherapy and surgical removal. There are several antineoplastic drugs available and the CSCs are protected against it by various defense mechanisms, which are CSC intrinsic and CSC extrinsic. CSCintrinsic mechanism involves deoxyribonucleic acid (DNA) repair, expression of drug pumps, and altered cell cycle, whereas CSCextrinsic mechanism involves the effect of tumor microenvironment on CSCs.
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Cancer Stem Cells and Its Response to Radiotherapy
Radiotherapy either alone or in combination with chemo therapy has curative potential in head and neck cancers and other solid tumors. They also help in the control of local recurrences of the primary tumor (Flow Chart 2). According to past studies, radiotherapy involves DNA amount in both CSC and nonCSC compartments, but damage repair was more robust in CSC and nonCSC population who underwent apoptosis more after the radiation.
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Targeting CSCs and Surface Markers 
